The microbial capsular polysaccharide galactoxylomannan inhibits IL-17A production in circulating T cells from rheumatoid arthritis patients

PLoS One. 2013;8(1):e53336. doi: 10.1371/journal.pone.0053336. Epub 2013 Jan 8.

Abstract

The persistence of activated T cells in rheumatoid arthritis (RA) synovium may be attributable to increased homing, increased retention or a possible imbalance between cell proliferation and programmed cell death. Induction of apoptosis may represent a potential therapeutic approach. Galactoxylomannan (GalXM) from the opportunistic fungus Cryptococcus neoformans can interact with T cells and induce T-cell apoptosis through the inhibition of CD45 phosphatase activity. The aim of this study was to determine the effect of GalXM on circulating T cells from patients with RA and the underlying mechanisms. GalXM immunomodulating effect on apoptosis and signal transduction pathway involved in IL-17A production was evaluated on T cells. RA T-cell apoptosis, higher than that of control T cells, was further increased by GalXM through induction of caspase-3 activation. Activated T cells expressing the CD45RO molecule and producing IL-17A were the main target of GalXM-induced apoptosis. GalXM induced consistent impairment of IL-17A production and inhibition of STAT3, which was hyperactivated in RA. In conclusion, GalXM triggered apoptosis of activated memory T cells and interfered with IL-17A production in RA. These data suggest therapeutic targeting of deleterious Th17 cells in RA and other autoimmune diseases.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Apoptosis / drug effects
  • Apoptosis / immunology
  • Arthritis, Rheumatoid / immunology*
  • Arthritis, Rheumatoid / pathology
  • Caspase 3 / genetics
  • Caspase 3 / immunology
  • Cell Proliferation / drug effects
  • Cells, Cultured
  • Cryptococcus neoformans / chemistry
  • Female
  • Fungal Polysaccharides / isolation & purification
  • Fungal Polysaccharides / pharmacology*
  • Gene Expression / drug effects
  • Humans
  • Immunologic Memory
  • Interleukin-17 / antagonists & inhibitors*
  • Interleukin-17 / biosynthesis
  • Interleukin-17 / immunology
  • Leukocyte Common Antigens / antagonists & inhibitors*
  • Leukocyte Common Antigens / genetics
  • Leukocyte Common Antigens / immunology
  • Lymphocyte Activation
  • Male
  • Middle Aged
  • Polysaccharides / isolation & purification
  • Polysaccharides / pharmacology*
  • STAT3 Transcription Factor / antagonists & inhibitors
  • STAT3 Transcription Factor / genetics
  • STAT3 Transcription Factor / immunology
  • Signal Transduction / drug effects
  • Synovial Fluid / cytology
  • Synovial Fluid / drug effects
  • Th17 Cells / drug effects*
  • Th17 Cells / immunology
  • Th17 Cells / pathology

Substances

  • Fungal Polysaccharides
  • IL17A protein, human
  • Interleukin-17
  • Polysaccharides
  • STAT3 Transcription Factor
  • STAT3 protein, human
  • galactoxylomannan
  • Leukocyte Common Antigens
  • PTPRC protein, human
  • Caspase 3